<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garbuzova-Davis S</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><pagination>22-28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7990719</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>170</volume><pubmed_abstract>Repairing the altered blood-CNS-barrier in amyotrophic lateral sclerosis (ALS) is imperative to prevent entry of detrimental blood-borne substances into the CNS. Cell transplantation with the goal of replacing damaged endothelial cells (ECs) may be a new therapeutic approach for barrier restoration. We showed positive effects of human bone marrow-derived CD34+ cells (hBM34+) and endothelial progenitor cells (hBM-EPCs) intravenous transplantation into symptomatic G93A SOD1 mutant mice on barrier reparative processes. These benefits mainly occurred by administered cells engraftment into vascular walls in ALS mice; however, additional studies are needed to confirm cell engraftment within capillaries. The aim of this investigation was to determine the presence of human DNA within microvascular</pubmed_abstract><journal>Brain research bulletin</journal><pubmed_title>Detection of endothelial cell-associated human DNA reveals transplanted human bone marrow stem cell engraftment into CNS capillaries of ALS mice.</pubmed_title><pmcid>PMC7990719</pmcid><funding_grant_id>1R01NS090962</funding_grant_id><funding_grant_id>R01 NS090962</funding_grant_id><pubmed_authors>Borlongan CV</pubmed_authors><pubmed_authors>Ehrhart J</pubmed_authors><pubmed_authors>Boccio KJ</pubmed_authors><pubmed_authors>Appel SH</pubmed_authors><pubmed_authors>Garbuzova-Davis S</pubmed_authors><pubmed_authors>Sanberg PR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Detection of endothelial cell-associated human DNA reveals transplanted human bone marrow stem cell engraftment into CNS capillaries of ALS mice.</name><description>Repairing the altered blood-CNS-barrier in amyotrophic lateral sclerosis (ALS) is imperative to prevent entry of detrimental blood-borne substances into the CNS. Cell transplantation with the goal of replacing damaged endothelial cells (ECs) may be a new therapeutic approach for barrier restoration. We showed positive effects of human bone marrow-derived CD34+ cells (hBM34+) and endothelial progenitor cells (hBM-EPCs) intravenous transplantation into symptomatic G93A SOD1 mutant mice on barrier reparative processes. These benefits mainly occurred by administered cells engraftment into vascular walls in ALS mice; however, additional studies are needed to confirm cell engraftment within capillaries. The aim of this investigation was to determine the presence of human DNA within microvascular</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-04T10:17:14.977Z</modification><creation>2025-04-04T10:17:14.977Z</creation></dates><accession>S-EPMC7990719</accession><cross_references><pubmed>33545308</pubmed><doi>10.1016/j.brainresbull.2021.01.020</doi></cross_references></HashMap>